Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters
NCT ID: NCT01578993
Last Updated: 2016-03-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2012-08-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Complication Rates Associated With PICC for Left vs Right
NCT01638702
Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters.
NCT02538159
Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion
NCT02752984
Study of Peripherally Inserted Central Catheter (PICC)-Related Infections in a Tropical Area
NCT02899546
Comparison of Early Phase Infections Risk Between Midline and Piccline Caheters: MIDLINE AND PICCLINE CATHETERS
NCT05264402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to comply with study requirements
* Written Informed Consent
Exclusion Criteria
* Current or recent upper extremity thrombosis, occlusion or stenosis
* Previous axillary lymph node dissection
* Skin inflammatory condition or rashes within 15 cm from insertion site
* Pre-existing history of hypercoagulability unrelated to malignant disease
* Participating in trial involving antithrombotic, anticoagulant or anti- infective drug therapies
* Positive blood culture within 48 hours from planned PICC placement
* Known, renal insufficiency with chronic creatinine levels \> 1.7 mg/dl
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Teleflex
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-PICC 2012-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.